Antioxidant Activity of Biofield Treated Proprietary Formulation Supplemented with Vitamins and Minerals in D-Galactose Induced Aging Dysfunction in Sprague Dawley Rats
Health & Wellness
A proprietary formulation was designed that consist of minerals (zinc, magnesium, iron, and copper) and vitamins (pyridoxine HCl, cyanocobalamin, and cholecalciferol). The present study was aimed to evaluate the impact of Consciousness Energy Healing Treatment (the Trivedi Effect®) on a novel test formulation in male Sprague Dawley (SD) rats for antioxidant activity. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. Additionally, three groups of animals were also received Biofield Energy Healing Treatment per se (day -15). The tissue lipid peroxidation data exhibited that the level of malondialdehyde (MDA) was altered by 20.86%, 12.92%, and 17.31% in the Biofield Energy Treated test formulation from day -15 (G7), Biofield Energy Treatment per se plus Biofield Energy Treated test formulation from day -15 (G8), and Biofield Energy Treatment per se animals plus untreated test formulation (G9) groups, respectively as compared to the untreated test formulation group (G4). Moreover, tissue myeloperoxidase (MPO) level was significantly reduced by 32.46%, 27.49%, 27.49%, and 23.71% in the Biofield Energy Treatment per se to animals from day -15 (G6), G7, G8, and G9 groups, respectively as compared to the G4 group. Antioxidant enzyme like SOD was significantly increased by 26.64%, 28.74%, 22.69%, 36.31%, and 36.11% in the Biofield Energy Treated test formulation (G5), G6, G7, G8, and G9, respectively compared to the disease control group (G2). Additionally, the level of catalase was significantly increased by 156.10%, 101.62%, 66.57%, and 179.17% in the G6, G7, G8, G9 groups, respectively compared to the G4 group. Further, LDH level was significantly reduced by 9.86% in the G9 group compared to the G4 group, while NO level was reduced by 11.42%, 10.76%, and 8.77% in the G5, G6, and G7 groups, respectively as compared to the G2 group. Altogether, results suggested that the Biofield Treated test formulation possess antioxidant potential and could be used to maintain bodies’ oxidative stress, immunity and boost overall health and aging.
Trivedi MK and Jana S
<a href="https://medwinpublishers.com/CCLSJ/volume.php?volumeId=391&issueId=1136">https://medwinpublishers.com/CCLSJ/volume.php?volumeId=391&issueId=1136</a>
Medwin Publishers
19-Feb-2021
English
Journal Article
In vitro Assessment of the Biofield Treated Test Item on Cardiac Function Using Rat Cardiomyocytes Cell Line (H9c2) via Multiparametric Analysis
Heart Health
<p style="text-align:justify;"><strong>Introduction:</strong> Heart disorders are the major concern of population health worldwide. According to WHO estimates 2018, 17.9 million peoples were died due to cardiovascular disorders. <br /><br /><strong>Aim:</strong> The aim of this study was to investigate the cardioprotective activity of Biofield Energy Treated test item, Dulbecco's Modified Eagle Medium (DMEM) using rat cardiomyocytes (H9c2). <br /><br /><strong>Methods:</strong> The test item (DMEM) was divided into three parts, first part received one-time Biofield Energy Treatment by a renowned Biofield Energy Healer, Mahendra Kumar Trivedi and was labeled as the one-time Biofield Energy Treated (BT-I) DMEM, while second part received the two-times Biofield Energy Treatment and is denoted as BT-II DMEM. The third part did not receive any treatment and defined as the untreated DMEM group. <br /><br /><strong>Results:</strong> Cell viability of the test samples by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay showed 89.03% and 98.49% in the BT-I and BT-II groups, respectively suggested a nontoxic and safe in nature of the tested test item. The BT-I group showed 16.01% restoration of cell viability. The level of lactate dehydrogenase (LDH) was significantly inhibited by 50.37% and 49.35% in the BT-I and BT-II groups, respectively compared to the untreated DMEM group. Moreover, percent protection of creatine kinase-myocardial band (CK-MB) by 49.48% and 59.79% in the BT-I and BT-II groups, respectively, compared to the untreated DMEM group. Reactive oxygen species (ROS) level in terms of mean fluorescence unit (FU) was reduced by 6.64% in the BT-I group than untreated DMEM. Besides, BT-I and BT-II groups significantly increased the level of % apoptotic cells by 63.16% and 97.37% (p≤0.05), respectively than untreated DMEM. <br /><br /><strong>Conclusion:</strong> Allover, results envisaged that Biofield Treatment significantly improved different cardiac parameters. Thus, Biofield Energy Treatment (The Trivedi Effect®) could be utilized as a cardio-protectant against several cardiac disorders such as coronary artery disease, heart attack, arrhythmias, heart failure, congenital heart disease, cardiomyopathy, etc.</p>
Mahendra Kumar Trivedi, Snehasis Jana
<a href="https://openaccesspub.org/jhc/article/1002">https://openaccesspub.org/jhc/article/1002</a>
Open Access Pub
Feb 15, 2019
English
Journal Article
10.14302/issn.2329-9487.jhc-19-2582